Different anti‐Műllerian hormone (AMH) levels respond to distinct ovarian stimulation methods in assisted reproductive technology (ART): Clues to better ART outcomes
Author:
Affiliation:
1. Women’s Clinic Oizumi Gakuen Lenia Medical Corporation Tokyo Japan
2. Department of Obstetrics and Gynecology Kyorin University School of Medicine Tokyo Japan
3. Artemis Women's Hospital Lenia Medical Corporation Tokyo Japan
Publisher
Wiley
Subject
Cell Biology,Reproductive Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/rmb2.12270
Reference23 articles.
1. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)
2. Contribution of the rate of change of antimüllerian hormone in estimating time to menopause for late reproductive-age women
3. Data-driven assessment of the human ovarian reserve
4. Update in polycystic ovary syndrome: new criteria of diagnosis and treatment in Japan
5. GnRH antagonists are safer than agonists: an update of a Cochrane review
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Evaluation of assisted reproductive technology treatment outcomes based on stimulation dosages and anti-Mullerian hormone levels;F1000Research;2022-09-12
2. Efficacy of Anti-Müllerian Hormone in Predicting the Levels of Sex Hormones and Pregnancy Outcomes in Patients with Polycystic Ovary Syndrome Undergoing IVF-ET;Pakistan Journal of Zoology;2022
3. A novel orally active gonadotropin‐releasing hormone antagonist, relugolix, is a potential substitute for injectable GnRH antagonists in controlled ovarian stimulation in assisted reproductive technology;Reproductive Medicine and Biology;2021-11-12
4. Exploring menstrual products: A systematic review and meta-analysis of reusable menstrual pads for public health internationally;PLOS ONE;2021-09-24
5. Fertility and pregnancy outcome among women undergoing assisted reproductive technology treatment in Windhoek, Namibia;Journal of Assisted Reproduction and Genetics;2021-02-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3